The company announced on December 30, 2025 that it will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT).

8-KRegulation FD DisclosureFiled Dec 30, 2025Period of report Dec 30, 2025Summary published (UTC) Oct 12, 2026

Key points

AI summary

The company announced on December 30, 2025 that it will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT).
The company said a live audio webcast of the fireside chat will be available on the company's Investor Relations website at ir.Labcorp.com and archived for replay.
The company filed this disclosure under Item 7.01 Regulation FD Disclosure and attached a press release dated December 30, 2025 as Exhibit 99.1.
In the press release, the company said nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of new drugs and therapeutic products approved by the FDA in 2024, and perform more than 700 million tests annually.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Participation in J.P. Morgan Healthcare Conference fireside chat

The company announced on December 30, 2025 that it will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13 at 4:30 p.m. (PT).

Source · Based on the filing body and exhibits

Fireside Chat Webcast

The company said a live audio webcast of the fireside chat will be available on the company's Investor Relations website at ir.Labcorp.com and archived for replay.

Source · Based on the filing body and exhibits

Reg FD disclosure and press release attachment

The company filed this disclosure under Item 7.01 Regulation FD Disclosure and attached a press release dated December 30, 2025 as Exhibit 99.1.

Source · Based on the filing body and exhibits

Company description in press release

In the press release, the company said nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of new drugs and therapeutic products approved by the FDA in 2024, and perform more than 700 million tests annually.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.